What about the efficacy issue? How do we decide whether or not it's worthwhile to publicly fund a drug if the impact on it is maybe only marginal? How do we make that tough decision?
On October 25th, 2018. See this statement in context.
On October 25th, 2018. See this statement in context.
Don Davies NDP Vancouver Kingsway, BC
What about the efficacy issue? How do we decide whether or not it's worthwhile to publicly fund a drug if the impact on it is maybe only marginal? How do we make that tough decision?
See context to find out what was said next.